MALCOLM JAN

SEC Form 4 insider trading activity

MALCOLM JAN has filed 10 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 9 of those filings fall inside the rolling window. Most recent filing: Jul 10, 2026.

On the most recent filing, MALCOLM JAN is listed as Director at UNITED THERAPEUTICS Corp. Inside the rolling window, MALCOLM JAN reported no open-market purchases and 9 open-market sales totaling $373K in UTHR. The largest disclosed transaction in the window is a sale of 325 UTHR shares on Jul 10, 2026, worth $179K.

Companies traded

Other insiders at UTHR

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$373K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
UTHRSale$179KJul 10SEC ↗
UTHRSale$24KMar 17SEC ↗
UTHRSale$25KMar 3SEC ↗
UTHRSale$24KFeb 17SEC ↗
UTHRSale$24KFeb 3SEC ↗
UTHRSale$23KJan 20SEC ↗
UTHRSale$25KJan 6SEC ↗
UTHRSale$26KDec 23SEC ↗
UTHRSale$24KDec 12SEC ↗
Showing 1–9 of 9
1 / 1

Earlier trades

Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.

DateTickerTypeValue
Sep 9, 2025UTHRSale$280K
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has MALCOLM JAN made?

MALCOLM JAN has filed 10 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.

Which companies does MALCOLM JAN trade?

MALCOLM JAN has filed SEC Form 4 disclosures for 1 company, including UTHR.

When was MALCOLM JAN's most recent SEC Form 4 filing?

MALCOLM JAN's most recent SEC Form 4 filing on Tracefour is dated Jul 10, 2026.

What is MALCOLM JAN's total buy and sell value in the current window?

Inside the rolling retention window, MALCOLM JAN bought $0 and sold $373K based on SEC Form 4 filings.

What was MALCOLM JAN's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 325 UTHR shares on 2026-07-10, worth $179K, per SEC Form 4 filings.